Tyrosine-protein kinase ABL1
Details
- Name
- Tyrosine-protein kinase ABL1
- Kind
- protein
- Organism
- Humans
- Protein
Name UniProt ID Tyrosine-protein kinase ABL1 P00519 Details
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB00171 ATP investigational, nutraceutical unknown inhibitor Details DB00619 Imatinib approved yes inhibitor Details DB01254 Dasatinib approved, investigational yes inhibitormultitarget Details DB04868 Nilotinib approved, investigational yes inhibitor Details DB05184 XL228 investigational unknown Details DB07831 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE experimental unknown Details DB08043 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA experimental unknown Details DB08231 Myristic acid experimental unknown Details DB08339 PD-166326 experimental unknown Details DB08350 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE experimental unknown Details DB03878 N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide experimental unknown Details DB08583 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide experimental unknown Details DB08896 Regorafenib approved yes inhibitor Details DB06616 Bosutinib approved yes inhibitor Details DB08901 Ponatinib approved, investigational yes inhibitor Details DB12323 Radotinib investigational yes antagonist Details DB12267 Brigatinib approved, investigational unknown inhibitor Details DB13749 Magnesium gluconate approved, investigational no substrateinducer Details DB12010 Fostamatinib approved, investigational unknown inhibitor Details DB14989 Umbralisib approved, investigational, withdrawn unknown inhibitor Details DB14989 Umbralisib approved, investigational, withdrawn unknown inhibitor Details DB12597 Asciminib approved, investigational yes inhibitorallosteric modulator Details